These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 25795692)
1. 25 mg versus 50 mg dose of rectal diclofenac for prevention of post-ERCP pancreatitis in Japanese patients: a retrospective study. Yoshihara T; Horimoto M; Kitamura T; Osugi N; Ikezoe T; Kotani K; Sanada T; Higashi C; Yamaguchi D; Ota M; Mizuno T; Gotoh Y; Okuda Y; Suzuki K BMJ Open; 2015 Mar; 5(3):e006950. PubMed ID: 25795692 [TBL] [Abstract][Full Text] [Related]
2. The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis. Okuno M; Shiroko J; Taguchi D; Yamaguchi K; Takada J; Imai S; Sato H; Thanabashi S Intern Med; 2018 Aug; 57(16):2289-2294. PubMed ID: 29607957 [TBL] [Abstract][Full Text] [Related]
3. Low-dose rectal diclofenac does not prevent post-ERCP pancreatitis in low- or high-risk patients. Katoh T; Kawashima K; Fukuba N; Masuda S; Kobatake H; Masaki K; Araki Y; Kawano K; Nishi K; Takenaka M; Ishihara S; Kinoshita Y J Gastroenterol Hepatol; 2020 Jul; 35(7):1247-1253. PubMed ID: 31788849 [TBL] [Abstract][Full Text] [Related]
4. Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study. Geraci G; Palumbo VD; D'Orazio B; Maffongelli A; Fazzotta S; Lo Monte AI Clin Ter; 2019; 170(5):e332-e336. PubMed ID: 31612188 [TBL] [Abstract][Full Text] [Related]
5. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. Lyu Y; Cheng Y; Wang B; Xu Y; Du W BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142 [TBL] [Abstract][Full Text] [Related]
6. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. Otsuka T; Kawazoe S; Nakashita S; Kamachi S; Oeda S; Sumida C; Akiyama T; Ario K; Fujimoto M; Tabuchi M; Noda T J Gastroenterol; 2012 Aug; 47(8):912-7. PubMed ID: 22350703 [TBL] [Abstract][Full Text] [Related]
8. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials. Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720 [TBL] [Abstract][Full Text] [Related]
9. Rectal administration of low-dose diclofenac does not reduce post-endoscopic retrograde cholangiopancreatography pancreatitis: a propensity score matching analysis. Sakai H; Iwai N; Sakagami J; Okuda T; Ohara T; Hattori C; Taniguchi M; Oka K; Hara T; Tsuji T; Komaki T; Kagawa K; Dohi O; Yasuda H; Konishi H; Itoh Y Surg Endosc; 2023 Apr; 37(4):2698-2705. PubMed ID: 36443561 [TBL] [Abstract][Full Text] [Related]
10. Diclofenac Does Not Reduce the Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Low-Risk Units. Rainio M; Lindström O; Udd M; Louhimo J; Kylänpää L J Gastrointest Surg; 2017 Aug; 21(8):1270-1277. PubMed ID: 28374181 [TBL] [Abstract][Full Text] [Related]
11. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. Mohammad Alizadeh AH; Abbasinazari M; Hatami B; Abdi S; Ahmadpour F; Dabir S; Nematollahi A; Fatehi S; Pourhoseingholi MA Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):349-354. PubMed ID: 27849643 [TBL] [Abstract][Full Text] [Related]
12. Rectal diclofenac does not prevent post-ERCP pancreatitis in consecutive high-risk and low-risk patients. Del Olmo Martínez L; Velayos Jiménez B; Almaraz Gómez A Rev Esp Enferm Dig; 2018 Aug; 110(8):505-509. PubMed ID: 29667415 [TBL] [Abstract][Full Text] [Related]
13. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial. Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032 [TBL] [Abstract][Full Text] [Related]
14. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography. Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656 [TBL] [Abstract][Full Text] [Related]
15. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis. Garg R; Mohan BP; Krishnamoorthi R; Rustagi T Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673 [TBL] [Abstract][Full Text] [Related]
16. Randomized trial of high-dose rectal diclofenac suppository and epinephrine spray on duodenal papilla for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Dar HA; Shah A; Javid G; Khan MA; Singh B; Sheikh NA; Ashraf A; Mohammad S Indian J Gastroenterol; 2021 Oct; 40(5):483-491. PubMed ID: 34767149 [TBL] [Abstract][Full Text] [Related]
17. Hydration with Lactated Ringer's solution combined with rectal diclofenac in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography. Del Olmo Martínez ML; Velayos Jiménez B; Almaraz-Gómez A Gastroenterol Hepatol; 2021 Jan; 44(1):20-26. PubMed ID: 32674877 [TBL] [Abstract][Full Text] [Related]
18. Intramuscular diclofenac for the prevention of post-ERCP pancreatitis: a randomized trial. Park SW; Chung MJ; Oh TG; Park JY; Bang S; Park SW; Song SY Endoscopy; 2015 Jan; 47(1):33-9. PubMed ID: 25409167 [TBL] [Abstract][Full Text] [Related]